Alcon to Acquire WaveTec Vision

As seen on the Company's website, Alcon, the global leader in eye care and the second largest division of Novartis Group, announced today that the company has entered into an agreement to acquire WaveTec® Vision, a privately-held company that developed the ORA System®, the first commercialized intra-operative guidance system for cataract surgeons implanting intraocular lenses (IOLs). Stradling's life science team, led by Bruce Feuchter, is representing WaveTec® Vision on the deal. Other members of the team include Shareholder Jeffrey Estes.